Medium impact
Actinic Keratoses Treatments (CPB 0567, reviewed 2026-04-10)
Aetna·Effective Apr 10, 2026
HCPCS J7308 is officially defined as "Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)." HCPCS J7308 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J7308 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.